These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10584661)

  • 1. Effectiveness and complications of treating neuroendocrine metastases, embolization versus chemoembolization.
    Hartnell GG
    J Vasc Interv Radiol; 1999; 10(10):1416-7. PubMed ID: 10584661
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver (RETNET): study protocol for a randomized controlled trial.
    Chen JX; Wileyto EP; Soulen MC
    Trials; 2018 Jul; 19(1):390. PubMed ID: 30016989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver.
    Kvols LK; Turaga KK; Strosberg J; Choi J
    J Natl Compr Canc Netw; 2009 Jul; 7(7):765-72. PubMed ID: 19635229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors.
    Fiore F; Del Prete M; Franco R; Marotta V; Ramundo V; Marciello F; Di Sarno A; Carratù AC; de Luca di Roseto C; Colao A; Faggiano A
    Endocrine; 2014 Sep; 47(1):177-82. PubMed ID: 24385266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial chemoembolization is ineffective for neuroendocrine tumors metastatic to the caudate lobe: a single institution review.
    Shirley LA; McNally M; Chokshi R; Jones N; Tassone P; Guy G; Khabiri H; Schmidt C; Shah M; Bloomston M
    World J Surg Oncol; 2015 May; 13():167. PubMed ID: 25927667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic intra-arterial therapies in metastatic neuroendocrine tumors: lessons from clinical practice.
    Grozinsky-Glasberg S; Kaltsas G; Kaltsatou M; Lev-Cohain N; Klimov A; Vergadis V; Uri I; Bloom AI; Gross DJ
    Endocrine; 2018 Jun; 60(3):499-509. PubMed ID: 29383678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference.
    Kennedy A; Bester L; Salem R; Sharma RA; Parks RW; Ruszniewski P;
    HPB (Oxford); 2015 Jan; 17(1):29-37. PubMed ID: 25186181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transcatheter arterial chemoembolization (TACE) using degradable starch microspheres (DSM) (DSM-TACE) for primary and metastatic liver neuroendocrine tumors from gastrointestinal neuroendocrine tumors].
    Fujisaki T; Ikari T; Kamei A; Takano K; Kuraoka K; Yoshimoto K; Hirasawa T; Asahara S
    Nihon Shokakibyo Gakkai Zasshi; 2008 Feb; 105(2):206-13. PubMed ID: 18250591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioembolization in the treatment of neuroendocrine tumors of the pancreas.
    John PK; Saif MW
    JOP; 2014 Jul; 15(4):332-4. PubMed ID: 25076336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment options for unresectable neuroendocrine liver metastases.
    John BJ; Davidson BR
    Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):357-69. PubMed ID: 22646257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioembolization and chemoembolization for unresectable neuroendocrine liver metastases - a systematic review.
    Yang TX; Chua TC; Morris DL
    Surg Oncol; 2012 Dec; 21(4):299-308. PubMed ID: 22846894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
    Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
    Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic neuroendocrine metastases: chemo- or bland embolization?
    Pitt SC; Knuth J; Keily JM; McDermott JC; Weber SM; Chen H; Rilling WS; Quebbeman EJ; Agarwal DM; Pitt HA
    J Gastrointest Surg; 2008 Nov; 12(11):1951-60. PubMed ID: 18709512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embolization of metastatic neuroendocrine tumor resulting in clinical manifestations of syndrome of inappropriate secretion of antidiuretic hormone.
    Yarmohammadi H; Erinjeri JP; Brown KT
    J Vasc Interv Radiol; 2015 Apr; 26(4):533-7. PubMed ID: 25805538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial embolization of hepatic metastases from neuroendocrine tumors].
    Libicher M; Bovenschulte H
    Radiologe; 2009 Mar; 49(3):233-41. PubMed ID: 19183927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.
    Ho AS; Picus J; Darcy MD; Tan B; Gould JE; Pilgram TK; Brown DB
    AJR Am J Roentgenol; 2007 May; 188(5):1201-7. PubMed ID: 17449759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioembolization Versus Chemoembolization for Neuroendocrine Metastases.
    Padia SA
    J Vasc Interv Radiol; 2021 Mar; 32(3):482-483. PubMed ID: 33376030
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemoembolization of hepatic metastases from intestinal neuroendocrine tumours.
    Kirchhoff T; Chavan A; Galanski M
    Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):141-3. PubMed ID: 10741925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study.
    Fiorentini G; Rossi S; Bonechi F; Vaira M; De Simone M; Dentico P; Bernardeschi P; Cantore M; Guadagni S
    J Chemother; 2004 Jun; 16(3):293-7. PubMed ID: 15330328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality treatment of neuroendocrine liver metastases.
    Karabulut K; Akyildiz HY; Lance C; Aucejo F; McLennan G; Agcaoglu O; Siperstein A; Berber E
    Surgery; 2011 Aug; 150(2):316-25. PubMed ID: 21801968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.